183 related articles for article (PubMed ID: 16314532)
1. The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation.
Harada K; Truong AB; Cai T; Khavari PA
Mol Cell Biol; 2005 Dec; 25(24):11122-30. PubMed ID: 16314532
[TBL] [Abstract][Full Text] [Related]
2. Class II PI3Ks α and β Are Required for Rho-Dependent Uterine Smooth Muscle Contraction and Parturition in Mice.
Sarker MAK; Aki S; Yoshioka K; Kuno K; Okamoto Y; Ishimaru K; Takuwa N; Takuwa Y
Endocrinology; 2019 Jan; 160(1):235-248. PubMed ID: 30476019
[TBL] [Abstract][Full Text] [Related]
3. The class II phosphoinositide 3-kinases PI3K-C2α and PI3K-C2β differentially regulate clathrin-dependent pinocytosis in human vascular endothelial cells.
Aung KT; Yoshioka K; Aki S; Ishimaru K; Takuwa N; Takuwa Y
J Physiol Sci; 2019 Mar; 69(2):263-280. PubMed ID: 30374841
[TBL] [Abstract][Full Text] [Related]
4. Novel roles for class II Phosphoinositide 3-Kinase C2β in signalling pathways involved in prostate cancer cell invasion.
Mavrommati I; Cisse O; Falasca M; Maffucci T
Sci Rep; 2016 Mar; 6():23277. PubMed ID: 26983806
[TBL] [Abstract][Full Text] [Related]
5. An Overview of Class II Phosphoinositide 3-Kinases.
Heng EYZ; Maffucci T
Curr Top Microbiol Immunol; 2022; 436():51-68. PubMed ID: 36243839
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.
Alliouachene S; Bilanges B; Chaussade C; Pearce W; Foukas LC; Scudamore CL; Moniz LS; Vanhaesebroeck B
Diabetologia; 2016 Jul; 59(7):1503-1512. PubMed ID: 27138914
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor stimulates translocation of the class II phosphoinositide 3-kinase PI3K-C2beta to the nucleus.
Banfic H; Visnjic D; Mise N; Balakrishnan S; Deplano S; Korchev YE; Domin J
Biochem J; 2009 Jul; 422(1):53-60. PubMed ID: 19496756
[TBL] [Abstract][Full Text] [Related]
8. PI3K-C2β limits mTORC1 signaling and angiogenic growth.
Kobialka P; Llena J; Deleyto-Seldas N; Munar-Gelabert M; Dengra JA; Villacampa P; Albinyà-Pedrós A; Muixi L; Andrade J; van Splunder H; Angulo-Urarte A; Potente M; Grego-Bessa J; Castillo SD; Vanhaesebroeck B; Efeyan A; Graupera M
Sci Signal; 2023 Nov; 16(813):eadg1913. PubMed ID: 38015911
[TBL] [Abstract][Full Text] [Related]
9. Class II phosphatidylinositol 3-kinase α and β isoforms are required for vascular smooth muscle Rho activation, contraction and blood pressure regulation in mice.
Islam S; Yoshioka K; Aki S; Ishimaru K; Yamada H; Takuwa N; Takuwa Y
J Physiol Sci; 2020 Mar; 70(1):18. PubMed ID: 32192434
[TBL] [Abstract][Full Text] [Related]
10. Essential role of class II phosphatidylinositol-3-kinase-C2α in sphingosine 1-phosphate receptor-1-mediated signaling and migration in endothelial cells.
Biswas K; Yoshioka K; Asanuma K; Okamoto Y; Takuwa N; Sasaki T; Takuwa Y
J Biol Chem; 2013 Jan; 288(4):2325-39. PubMed ID: 23192342
[TBL] [Abstract][Full Text] [Related]
11. Class II phosphoinositide 3-kinase alpha-isoform regulates Rho, myosin phosphatase and contraction in vascular smooth muscle.
Wang Y; Yoshioka K; Azam MA; Takuwa N; Sakurada S; Kayaba Y; Sugimoto N; Inoki I; Kimura T; Kuwaki T; Takuwa Y
Biochem J; 2006 Mar; 394(Pt 3):581-92. PubMed ID: 16336212
[TBL] [Abstract][Full Text] [Related]
12. Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors.
Arcaro A; Zvelebil MJ; Wallasch C; Ullrich A; Waterfield MD; Domin J
Mol Cell Biol; 2000 Jun; 20(11):3817-30. PubMed ID: 10805725
[TBL] [Abstract][Full Text] [Related]
13. Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration.
Maffucci T; Cooke FT; Foster FM; Traer CJ; Fry MJ; Falasca M
J Cell Biol; 2005 Jun; 169(5):789-99. PubMed ID: 15928202
[TBL] [Abstract][Full Text] [Related]
14. Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.
Chikh A; Ferro R; Abbott JJ; Piñeiro R; Buus R; Iezzi M; Ricci F; Bergamaschi D; Ostano P; Chiorino G; Lattanzio R; Broggini M; Piantelli M; Maffucci T; Falasca M
Oncotarget; 2016 Apr; 7(14):18325-45. PubMed ID: 26934321
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the Class II PI3K-C2β Potentiates Insulin Signaling and Sensitivity.
Alliouachene S; Bilanges B; Chicanne G; Anderson KE; Pearce W; Ali K; Valet C; Posor Y; Low PC; Chaussade C; Scudamore CL; Salamon RS; Backer JM; Stephens L; Hawkins PT; Payrastre B; Vanhaesebroeck B
Cell Rep; 2015 Dec; 13(9):1881-94. PubMed ID: 26655903
[TBL] [Abstract][Full Text] [Related]
16. Class II PI3K Functions in Cell Biology and Disease.
Gulluni F; De Santis MC; Margaria JP; Martini M; Hirsch E
Trends Cell Biol; 2019 Apr; 29(4):339-359. PubMed ID: 30691999
[TBL] [Abstract][Full Text] [Related]
17. Regulation of neuron survival through an intersectin-phosphoinositide 3'-kinase C2beta-AKT pathway.
Das M; Scappini E; Martin NP; Wong KA; Dunn S; Chen YJ; Miller SL; Domin J; O'Bryan JP
Mol Cell Biol; 2007 Nov; 27(22):7906-17. PubMed ID: 17875942
[TBL] [Abstract][Full Text] [Related]
18. Class II PI3Ks at the Intersection between Signal Transduction and Membrane Trafficking.
Margaria JP; Ratto E; Gozzelino L; Li H; Hirsch E
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30884740
[TBL] [Abstract][Full Text] [Related]
19. Are class II phosphoinositide 3-kinases potential targets for anticancer therapies?
Traer CJ; Foster FM; Abraham SM; Fry MJ
Bull Cancer; 2006 May; 93(5):E53-8. PubMed ID: 16777618
[TBL] [Abstract][Full Text] [Related]
20. Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesis.
Tibolla G; Piñeiro R; Chiozzotto D; Mavrommati I; Wheeler AP; Norata GD; Catapano AL; Maffucci T; Falasca M
PLoS One; 2013; 8(1):e53808. PubMed ID: 23320105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
